PA
ZYME icon

Perceptive Advisors’s Zymeworks ZYME Stock Holding History

Perceptive Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87.9M Buy
3,510,078
+248,228
+8% +$5.87M 1.72% 18
2025
Q4 		$85.9M Buy
3,261,850
+1,171,187
+56% +$25.5M 1.53% 21
2025
Q3 		$35.7M Buy
2,090,663
+815,389
+64% +$11.7M 1.03% 29
2025
Q2 		$16M Sell
1,275,274
-589,398
-32% -$7.02M 0.59% 40
2025
Q1 		$22.2M Sell
1,864,672
-265,348
-12% -$3.62M 0.78% 34
2024
Q4 		$31.2M Sell
2,130,020
-50,000
-2% -$699K 0.86% 33
2024
Q3 		$27.4M Buy
2,180,020
+512,309
+31% +$5.58M 0.58% 45
2024
Q2 		$14.2M Buy
1,667,711
+592,904
+55% +$5.28M 0.34% 62
2024
Q1 		$11.3M Hold
1,074,807
– – 0.2% 73
2023
Q4 		$11.2M Sell
1,074,807
-371,316
-26% -$2.96M 0.25% 63
2023
Q3 		$9.17M Sell
1,446,123
-970,109
-40% -$7.16M 0.31% 60
2023
Q2 		$20.9M Sell
2,416,232
-962,266
-28% -$8.62M 0.6% 47
2023
Q1 		$30.5M Sell
3,378,498
-1,132,777
-25% -$9.88M 0.9% 37
2022
Q4 		$35.5M Buy
4,511,275
+111,176
+3% +$781K 1% 31
2022
Q3 		$27.1M Buy
4,400,099
+267,565
+6% +$1.61M 0.79% 35
2022
Q2 		$21.9M Sell
4,132,534
-1,193,081
-22% -$7.22M 0.69% 36
2022
Q1 		$34.9M Buy
5,325,615
+1,645,770
+45% +$14.7M 0.7% 37
2021
Q4 		$60.3M Hold
3,679,845
– – 0.93% 27
2021
Q3 		$107M Sell
3,679,845
-625,755
-15% -$20.8M 1.55% 16
2021
Q2 		$149M Sell
4,305,600
-25,268
-0.6% -$802K 1.94% 13
2021
Q1 		$137M Buy
4,330,868
+29,869
+0.7% +$1.21M 1.73% 16
2020
Q4 		$203M Sell
4,300,999
-100,000
-2% -$4.64M 2.18% 10
2020
Q3 		$205M Buy
4,400,999
+820,000
+23% +$28.2M 2.99% 8
2020
Q2 		$129M Buy
3,580,999
+20,000
+0.6% +$737K 2.09% 16
2020
Q1 		$126M Buy
3,560,999
+1,157,973
+48% +$47.4M 3.28% 8
2019
Q4 		$109M Buy
2,403,026
+14,136
+0.6% +$514K 2.17% 14
2019
Q3 		$59.2M Buy
2,388,890
+20,000
+0.8% +$501K 1.6% 17
2019
Q2 		$52.1M Buy
2,368,890
+1,795,000
+313% +$32.9M 1.2% 20
2019
Q1 		$8.53M Hold
573,890
– – 0.24% 63
2018
Q4 		$7.2M Sell
573,890
-550,000
-49% -$7.22M 0.27% 58
2018
Q3 		$16.9M Hold
1,123,890
– – 0.45% 45
2018
Q2 		$15.9M Buy
1,123,890
+430,000
+62% +$6.66M 0.42% 49
2018
Q1 		$7.78M Sell
693,890
-83,607
-11% -$904K 0.22% 69
2017
Q4 		$5.55M Buy
777,497
+46,729
+6% +$384K 0.18% 73
2017
Q3 		$5.83M Hold
730,768
– – 0.22% 64
2017
Q2 		$6.1M Buy
+730,768
New +$8.18M 0.31% 62

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Perceptive Advisors's ZYME Position: Q1 2026 in Review

Perceptive Advisors increased its Zymeworks (ZYME) stake by 7.6% in Q1 2026, buying an estimated $5.87M and bringing the position to 3,510,078 shares worth $87.9M. The position accounts for 1.72% of the portfolio, ranked #18.

Perceptive Advisors first reported a position in ZYME in Q2 2017 and has held it in 36 quarters since. The position peaked at $205M in Q3 2020. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Perceptive Advisors held 3,510,078 shares of Zymeworks worth $87.9M as of Q1 2026.
  • Perceptive Advisors bought 248,228 Zymeworks shares in Q1 2026, an estimated $5.87M.
  • Zymeworks made up 1.72% of Perceptive Advisors's portfolio in Q1 2026, its #18 holding.
  • Perceptive Advisors first reported a position in Zymeworks in Q2 2017 and has held it in 36 quarters since.
  • Perceptive Advisors's Zymeworks position peaked at $205M in Q3 2020.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.